Marksans Pharma Limited has informed the Exchange about Copy of Newspaper Publication of audited financial results for the quarter and year ended 31 March 2025.
MARKSANS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Marksans Pharma has submitted copies of newspaper advertisements to BSE and NSE containing its audited financial results for the fourth quarter and full year ended March 31, 2025. The results were published on May 21, 2025 in Business Standard (English) and Lakshadeep (Marathi). This submission is made under Regulation 47 of SEBI's Listing Obligations and Disclosure Requirements (LODR) Regulations, 2015. The filing itself is a routine compliance document and does not include the detailed financial numbers — those would have appeared in the actual newspaper advertisements.
This is a routine regulatory compliance filing with no immediate impact on shareholders. Investors should look at the underlying Q4 and FY25 audited results for actual performance details, which would have been reported separately.